×

Antisense modulation of bcl-x expression

  • US 6,214,986 B1
  • Filed: 06/02/1999
  • Issued: 04/10/2001
  • Est. Priority Date: 10/07/1998
  • Status: Expired due to Term
First Claim
Patent Images

1. An antisense compound 8 to 30 nucleotides in length targeted to a nucleic acid molecule encoding a human bcl-x, wherein said antisense compound modulates the expression of human bcl-x, and wherein said antisense compound is an antisense oligonucleotide which comprises at least an 8 nucleobase portion of SEQ ID NO:

  • 43, 44, 46, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, or 66.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×